Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenzhen Hui

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
International Journal of Biological Macromolecules|January 18, 2024
Dynamic carboxymethyl chitosan prodrug hydrogel precisely mediates robust therapy on wound infectionZhenzhen Hui, Xinyuan Pan, Ying Li, et al.
Journal of Translational Medicine|June 23, 2026
Circulating CD28<sup>-</sup>KLRG1<sup>+</sup>CD8<sup>+</sup> T cells involve in systemic and local immunity that predicts chemoimmunotherapy outcomes in advanced NSCLCJian Zhou, Hongyu Bie, Yi You, et al.
Scientific Reports|February 7, 2026
Randomized pilot study of camrelizumab with or without autologous cytokine-induced killer cells in refractory clear cell renal cell carcinomaShuzhan Li, Jing Qin, Qian Sun, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
International Journal of Biological Macromolecules|January 18, 2024
Dynamic carboxymethyl chitosan prodrug hydrogel precisely mediates robust therapy on wound infectionZhenzhen Hui, Xinyuan Pan, Ying Li, et al.
Journal of Translational Medicine|June 23, 2026
Circulating CD28<sup>-</sup>KLRG1<sup>+</sup>CD8<sup>+</sup> T cells involve in systemic and local immunity that predicts chemoimmunotherapy outcomes in advanced NSCLCJian Zhou, Hongyu Bie, Yi You, et al.
Scientific Reports|February 7, 2026
Randomized pilot study of camrelizumab with or without autologous cytokine-induced killer cells in refractory clear cell renal cell carcinomaShuzhan Li, Jing Qin, Qian Sun, et al.
Pageof 4